ovarian cancer

News

GSK’s ZEJULA gets green light for NHS use

The UK’s National Institute for Health and Care Excellence (NICE) has recommended GlaxoSmithKline’s (GSK) ZEJULA (niraparib) for some forms of ovarian, fallopian tube, and peritoneal cancer

News

UK startup Leucid raises £11.5m for solid tumour CAR-T thera...

CAR-T therapies have revolutionised the treatment of some blood cancers, but so far haven't been able to repeat that success in solid tumours.

Digital

Shaping the future of ovarian cancer diagnosis with femtech

Israeli femtech start-up GinaLife is developing a platform of biomarker strategies supported by artificial intelligence and data science for the early detection of problems in women's healt

News

NICE’s track record in cancer drugs: the impact of the CDF and the role of interim funding

NICE backs ovarian cancer and multiple myeloma combination d...

NICE has recommended funding for two cancer drug combinations for ovarian cancer and multiple myeloma.

News

EU regulators back uses for AZ's Lynparza in prostate and ov...

AstraZeneca may have had a rough ride following a safety scare with its COVID-19 vaccine, but the company’s busy pipeline is producing successes in other areas.

News